{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["N/A"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001008514"],"sample_count":["18"],"description":["EGA dataset EGAD00001008514"],"repository":["EGA"],"title":["Unravelling the contribution of HIF pathway and its therapeutic potential in human AML leukemia-initiating cells"],"additional_accession":[]},"is_claimable":false,"name":"ff3d9e55-4b3f-41c5-a069-9eb1dea0d5c5 - samples","description":"We performed single cell RNA sequencing (scRNA-seq) from bone marrow on 11 pediatric (0-14 years-old) and adolescent and young adult (AYA) (15-39 years-old) de novo AML samples (Dx) (4 inv(16), 3 t(8;21) and 4 rMLL). In addition, for some patients also relapse sample was sequenced (2 inv(16), 2 t(8;21) and 3 rMLL). Cells were sorted into CD34+/CD38- and CD34-/CD38+ and sequenced separately.","dates":{"updated":"2022-02-01 16:15:58"},"accession":"EGAD00001008514","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001002509","EGAS00001005980"]}}